Literature DB >> 17651974

Losartan and its interaction with copper(II): biological effects.

Susana B Etcheverry1, Evelina G Ferrer, Luciana Naso, Daniel A Barrio, Luis Lezama, Teófilo Rojo, Patricia A M Williams.   

Abstract

Losartan, the potassium salt of 2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazol, is an efficient antihypertensive drug. The vibrational FTIR and Raman spectra of Losartan (its anionic and protonated forms) are discussed. In addition, the copper(II) complex of Losartan was obtained and characterized as a microcrystalline powder. The metal center is bound to the ligand through the nitrogen atoms of the tetrazolate moiety as determined by vibrational spectroscopy. The compound is a dimer with the metal centers in a tetragonal distorted environment but the presence of a monomeric impurity has been determined by EPR spectroscopy. The antioxidant properties of the complex (superoxide dismutase mimetic activity) and its effect on the proliferation and morphology of two osteoblast-like cells in culture are reported. The new compound exerted more toxic effects on tumoral cells than the copper(II) ion and Losartan.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651974     DOI: 10.1016/j.bmc.2007.06.056

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Cu(Nor)2·5H2O, a complex of Cu(II) with Norfloxacin: theoretic approach and biological studies. Cytotoxicity and genotoxicity in cell cultures.

Authors:  A L Di Virgilio; I E León; C A Franca; I Henao; G Tobón; S B Etcheverry
Journal:  Mol Cell Biochem       Date:  2012-12-14       Impact factor: 3.396

2.  Experimental and DFT characterization, antioxidant and anticancer activities of a Cu(II)-irbesartan complex: structure-antihypertensive activity relationships in Cu(II)-sartan complexes.

Authors:  María S Islas; Alicia Luengo; Carlos A Franca; Mercedes Griera Merino; Laura Calleros; Manuel Rodriguez-Puyol; Luis Lezama; Evelina G Ferrer; Patricia A M Williams
Journal:  J Biol Inorg Chem       Date:  2016-08-09       Impact factor: 3.358

3.  Angiotensin II type 1 receptor blockers increase tolerance of cells to copper and cisplatin.

Authors:  Pieter Spincemaille; Gursimran Chandhok; Andree Zibert; Hartmut Schmidt; Jef Verbeek; Patrick Chaltin; Bruno P Cammue; David Cassiman; Karin Thevissen
Journal:  Microb Cell       Date:  2014-10-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.